Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PISCOPO PHARMA : revenue, balance sheet and financial ratios

PISCOPO PHARMA is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in RUEIL-MALMAISON (92500), this company of category PME shows in 2025 a net income negative of -87 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PISCOPO PHARMA (SIREN 850948035)
Indicator 2025 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C N/C
Net income -87 292 € -24 735 € 23 638 € 457 234 € 356 610 € 94 943 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PISCOPO PHARMA records a net loss of 87 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-87 292 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

54.377%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

48.107%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

62.3%

Solvency indicators evolution
PISCOPO PHARMA

Sector positioning

Debt ratio
54.38 2025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average +8 pts over 3 years

In 2025, the debt ratio of PISCOPO PHARMA (54.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
48.11% 2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average -10 pts over 3 years

In 2025, the financial autonomy of PISCOPO PHARMA (48.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 178.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

178.851

Liquidity indicators evolution
PISCOPO PHARMA

Sector positioning

Liquidity ratio
178.85 2025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average -15 pts over 3 years

In 2025, the liquidity ratio of PISCOPO PHARMA (178.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PISCOPO PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PISCOPO PHARMA with other companies in the same sector:

Frequently asked questions about PISCOPO PHARMA

What is the revenue of PISCOPO PHARMA ?

The revenue of PISCOPO PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is PISCOPO PHARMA profitable?

PISCOPO PHARMA recorded a net loss in 2025.

Where is the headquarters of PISCOPO PHARMA ?

The headquarters of PISCOPO PHARMA is located in RUEIL-MALMAISON (92500), in the department Hauts-de-Seine.

Where to find the tax return of PISCOPO PHARMA ?

The tax return of PISCOPO PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PISCOPO PHARMA operate?

PISCOPO PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.